Hubei Hongyuan Pharmaceutical Technology Co Ltd

SZSE:301246 (China)   Ordinary Shares - Class A
Â¥ 14.48 (-0.89%) Jun 13
116.77
P/B:
1.32
Market Cap:
Â¥ 5.79B ($ 798.62M)
Enterprise V:
Â¥ 4.17B ($ 574.76M)
Volume:
1.99M
Avg Vol (2M):
5.88M
Volume:
1.99M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hubei Hongyuan Pharmaceutical Technology Co Ltd ( SZSE:301246 ) from 2023 to Jun 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hubei Hongyuan Pharmaceutical Technology stock (SZSE:301246) PE ratio as of Jun 13 2024 is 116.77. More Details

Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) PE Ratio (TTM) Chart

To

Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) PE Ratio (TTM) Historical Data

Total 299
  • 1
  • 2
  • 3
  • 4
Hubei Hongyuan Pharmaceutical Technology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-13 116.8 2024-04-03 144.1
2024-06-12 117.8 2024-04-02 144.3
2024-06-11 116.2 2024-04-01 145.5
2024-06-07 114.9 2024-03-29 138.7
2024-06-06 111.8 2024-03-28 139.7
2024-06-05 116.6 2024-03-27 76.3
2024-06-04 118.9 2024-03-26 79.3
2024-06-03 119.5 2024-03-25 79.2
2024-05-31 124.1 2024-03-22 82.1
2024-05-30 121.9 2024-03-21 85.8
2024-05-29 123.7 2024-03-20 89.0
2024-05-28 122.7 2024-03-19 99.5
2024-05-27 124.2 2024-03-18 100.3
2024-05-24 125.0 2024-03-15 98.0
2024-05-23 125.6 2024-03-14 97.9
2024-05-22 129.2 2024-03-13 97.3
2024-05-21 128.2 2024-03-12 97.7
2024-05-20 130.2 2024-03-11 95.6
2024-05-17 130.7 2024-03-08 93.8
2024-05-16 129.9 2024-03-07 93.8
2024-05-15 129.9 2024-03-06 95.5
2024-05-14 134.0 2024-03-05 95.4
2024-05-13 136.3 2024-03-04 98.0
2024-05-10 144.7 2024-03-01 97.3
2024-05-09 141.8 2024-02-29 96.9
2024-05-08 138.0 2024-02-28 94.5
2024-05-07 134.8 2024-02-27 99.0
2024-05-06 134.5 2024-02-26 97.0
2024-04-30 131.4 2024-02-23 95.6
2024-04-29 130.0 2024-02-22 95.1
2024-04-26 126.3 2024-02-21 94.1
2024-04-25 126.2 2024-02-20 93.0
2024-04-24 124.9 2024-02-19 91.1
2024-04-23 121.4 2024-02-08 91.0
2024-04-22 120.4 2024-02-07 86.0
2024-04-19 118.4 2024-02-06 85.3
2024-04-18 119.9 2024-02-05 79.0
2024-04-17 122.0 2024-02-02 85.6
2024-04-16 114.7 2024-02-01 90.0
2024-04-15 126.5 2024-01-31 90.2
2024-04-12 133.8 2024-01-30 95.6
2024-04-11 139.3 2024-01-29 99.6
2024-04-10 140.8 2024-01-26 101.8
2024-04-09 143.3 2024-01-25 103.2
2024-04-08 139.8 2024-01-24 99.2

Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.